Iniparib
TCD11418
Phase 2 small_molecule completed
Quick answer
Iniparib for Breast Cancer, Metastatic is a Phase 2 program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Breast Cancer, Metastatic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed